4-[3-(1-methyl-1H-indol-3-yl)-5-{[(2Z)-4-oxo-1,3-thiazolidin-2-ylidene]amino}-1H-pyrazol-1-yl]benzonitrile

ID: ALA5286267

Max Phase: Preclinical

Molecular Formula: C22H16N6OS

Molecular Weight: 412.48

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2cc(/N=C3/NC(=O)CS3)n(-c3ccc(C#N)cc3)n2)c2ccccc21

Standard InChI:  InChI=1S/C22H16N6OS/c1-27-12-17(16-4-2-3-5-19(16)27)18-10-20(24-22-25-21(29)13-30-22)28(26-18)15-8-6-14(11-23)7-9-15/h2-10,12H,13H2,1H3,(H,24,25,29)

Standard InChI Key:  BWUQMPAFPHOMEW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   -0.1768   -0.1439    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6481   -0.1439    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8982   -0.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2447   -1.4186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4226   -0.9266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6949   -1.1614    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9083   -1.9580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7049   -2.1714    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7384   -3.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9856   -3.2979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4684   -2.6502    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4526   -3.4248    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2193   -1.1401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4327   -1.9367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2737   -1.9702    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5591   -1.2174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9115   -0.7002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3283   -0.9155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4526   -0.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8093    0.4201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0363    0.1226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0605    0.5702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6483    1.2846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0601    1.9963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8851    1.9963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2967    1.2864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8888    0.5702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6861   -2.6845    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2974    2.7106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7098    3.4248    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  1  5  2  0
  5  4  1  0
  3  6  1  0
  6  7  2  0
  8  7  1  0
  8  9  1  0
  9 10  1  0
 11 10  1  0
  7 11  1  0
  9 12  2  0
  5 13  1  0
 14 13  2  0
 14 15  1  0
 15 16  1  0
 17 16  2  0
 13 17  1  0
 16 18  1  0
 19 18  2  0
 20 19  1  0
 21 20  2  0
 17 21  1  0
  2 22  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 22 27  1  0
 15 28  1  0
 25 29  1  0
 29 30  3  0
M  END

Alternative Forms

  1. Parent:

    ALA5286267

    ---

Associated Targets(Human)

BEAS-2B (690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 412.48Molecular Weight (Monoisotopic): 412.1106AlogP: 3.75#Rotatable Bonds: 3
Polar Surface Area: 88.00Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.57CX Basic pKa: 0.84CX LogP: 4.17CX LogD: 3.95
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.56Np Likeness Score: -1.42

References

1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N..  (2023)  Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors.,  14  (3): [PMID:36970141] [10.1039/d2md00442a]

Source